Is BioCryst Pharmaceuticals, Inc. (BCRX) a Buy, Sell, or Hold?
NASDAQ : BCRX
BioCryst Pharmaceuticals, Inc. — Earnings Estimates
$9.74 USD
$0.16 (1.67%)
- Volume
- 2.81M
- Average Volume
- 4.95M
- Market Capitalization
- $2.48B
- P/E Ratio
- -5.63
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $11.22
- Year Low
- $6.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
Annual earnings financials
BCRX financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.
BCRX Estimated and Actual Revenue by Quarter
BCRX Estimated and Actual EPS by Quarter
BCRX Analyst Forecasts — EBITDA & EBIT
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 3 | -50.35M | -48.88M | -49.51M | -51.15M | -49.66M | -50.3M |
| 2027-09-30 | 3 | -49.38M | -47.94M | -48.57M | -50.17M | -48.71M | -49.34M |
| 2027-06-30 | 3 | -47.94M | -46.54M | -47.14M | -48.7M | -47.28M | -47.89M |
| 2027-03-31 | 3 | -42.41M | -41.17M | -41.7M | -43.08M | -41.82M | -42.37M |
| 2026-12-31 | 5 | -42.69M | -41.44M | -41.98M | -43.37M | -42.1M | -42.65M |
| 2026-09-30 | 6 | -40.98M | -40.63M | -40.85M | -41.63M | -41.28M | -41.5M |
BCRX Analyst Forecasts — Net Income & SGA Expense
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2027-12-31 | 3 | 58.94M | 61.25M | 59.93M | 118.29M | 121.84M | 119.82M |
| 2027-09-30 | 3 | 55.86M | 58.05M | 56.8M | 116.02M | 119.5M | 117.53M |
| 2027-06-30 | 3 | 50.41M | 52.38M | 51.26M | 112.62M | 116M | 114.08M |
| 2027-03-31 | 3 | 33.19M | 34.49M | 33.75M | 99.63M | 102.62M | 100.92M |
| 2026-12-31 | 5 | 34.91M | 36.28M | 35.51M | 100.29M | 103.3M | 101.59M |
| 2026-09-30 | 6 | 22.32M | 23.19M | 22.7M | 98.32M | 99.16M | 98.86M |
BCRX Analyst Forecasts — Revenue & EPS
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2027-12-31 | 3 | 198.55M | 204.51M | 201.12M | 1 | 0.24328 | 0.25281 | 0.2474 |
| 2027-09-30 | 3 | 194.74M | 200.59M | 197.27M | 1 | 0.23056 | 0.2396 | 0.23447 |
| 2027-06-30 | 3 | 189.03M | 194.71M | 191.49M | 1 | 0.20807 | 0.21623 | 0.2116 |
| 2027-03-31 | 3 | 167.22M | 172.25M | 169.4M | 1 | 0.13701 | 0.14238 | 0.13933 |
| 2026-12-31 | 5 | 168.33M | 173.39M | 170.52M | 1 | 0.14412 | 0.14977 | 0.14656 |
| 2026-09-30 | 6 | 165.03M | 166.44M | 165.94M | 2 | 0.09213248 | 0.09574405 | 0.093694 |